High cardiovascular health was associated with a reduced effect of insulin resistance on all-cause and cardiovascular mortality risk.

The FDA approved 3 new color additives, a move that will provide manufacturers with a wider range of natural color options to safely be used in food.

A Cornell University project to save babies born with serious heart defects has lost key funding just days after it was approved.

Topline results were announced from a phase 3 study comparing aficamten with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy.

The FDA has approved the SAPIEN 3 platform, a TAVR therapy, for patients with severe aortic stenosis without symptoms.

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

Men with gout and obesity receiving febuxostat-based ULT were less likely to achieve SU targets and more frequently experienced disease flares.

Over a 10-year period, METS-IR effectively predicted CV events among patients with PsA, with values greater than 2.48 at baseline conferring the greatest risk.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

No significant association was observed between viremia history during ART and CVD risk in a large international cohort of patients with HIV infection.

President Donald Trump has chosen Dr Casey Means, a wellness influencer and health tech entrepreneur, to be his nominee for surgeon general.

Survival outcomes have improved since 2014 among young, competitive athletes with SCA, although these improvements are mostly among White patients.